Phathom Pharmaceuticals, Inc. (PHAT) Tops Q4 EPS by 42c
Tweet
Share
E-mail
Get Alerts PHAT Hot Sheet
Join SI Premium – FREE
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) reported Q4 EPS of ($0.79), $0.42 better than the analyst estimate of ($1.21). Revenue for the quarter came in at $29.7 million versus the consensus estimate of $26.04 million.
For earnings history and earnings-related data on Phathom Pharmaceuticals, Inc. (PHAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UGI shares spike on reported KKR bid for the company
- Anthropic pre-IPO credit facility to climb past $10B target - Bloomberg
- Infleqtion opens new Colorado headquarters for quantum work
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
